Join Danielle from GO2 as she talks to Dr Joshua Sabari and Larry Gershon about late-stage EGFR-mutated non-small cell lung cancer and treatment plans. Episode learning points & Disclosures: <a href= "https://education.webmd.com/viewarticle/1001870" target="_blank" rel= "noopener">https://education.webmd.com/viewarticle/1001870?ecd=bdc_podcast_libsyn_mscpedu</a>

Join Danielle from GO2 as she talks to Dr Joshua Sabari and Larry Gershon about late-stage EGFR-mutated non-small cell lung cancer and treatment plans. Episode learning points & Disclosures: https://education.webmd.com/viewarticle/1001870?ecd=bdc_podcast_libsyn_mscpedu

Join Danielle from GO2 as she talks to Dr Joshua Sabari and Larry Gershon about late-stage EGFR-mutated non-small cell lung cancer and treatment plans. Episode learning points &amp; Disclosures: <a href="https://education.webmd.com/viewarticle/1001870" rel="noopener noreferrer">https://education.webmd.com/viewarticle/1001870?ecd=bdc_podcast_libsyn_mscpedu</a>

Understanding Treatment for Advanced EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC)

Join Danielle from GO2 as she talks to Dr Joshua Sabari and Larry Gershon about EGFR-mutated non-small cell lung cancer and treatment plans.

Share Understanding Treatment for Advanced EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC)

Sign up to save your podcasts

Understanding Treatment for Advanced EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC)

Understanding Treatment for Advanced EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC)